vcvibes

Newvale Capital

Emerging manager

Built from this firm's Form D filings. The firm files no SEC adviser report.

HQ
CO

NewVale Capital is a venture firm focused on the services architecture of the life science industry. Its debut fund was announced as oversubscribed. The firm led by Founder and Managing Partner Todd Holmes, and it lists executive partners, operating partners, and other team members. Its portfolio includes companies in pharmaceutical manufacturing software, contract manufacturing, clinical data validation, engineering services, and sterilization.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsLife sciences and research toolsNot enough dated deals
RegionsNot statedNot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
NewVale Capital Fund II LP

NewVale Capital is a sector-specialist pharma services growth equity firm. It invests in proven, revenue-generating services and enabling technology businesses serving the life sciences ecosystem, in the window between commercial proof points and commercial scale. Inferred from the firm's website

approx. 2026$250M (Form D)Raising

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://newvalecapital.com
  2. https://newvalecapital.com/contact/
  3. https://newvalecapital.com/team/
  4. https://newvalecapital.com/
  5. https://newvalecapital.com/team/scott-waldman/
  6. https://newvalecapital.com/team/todd-holmes/
  7. https://newvalecapital.com/team/anne-whitaker/
  8. https://newvalecapital.com/news/
  9. https://newvalecapital.com/approach/
  10. https://newvalecapital.com/team/todd-smith/

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026